等待开盘 04-01 09:30:00 美东时间
+3.870
+5.02%
Hexcel completes EFIPreg R&D project; CDTI grant rises to €470,993 Hexcel completed its Efficient Prepreg (EFIPreg) research and development project to develop a new aerospace prepreg aimed at improving efficiency and scalability for high-rate aircraft production. The work was supported by a €470,99
03-25 21:58
What's the best drone stock right now for investors? Seeking Alpha analysts Brett Aschcroft Green and Michael Del Monte offer their picks. Brett Aschcroft Green: Anytime I look to create a sleeve or a...
03-18 05:11
U.S. equities traded in mixed territory Friday morning as Wall Street weighed a stark downward revision to fourth-quarter economic growth against a sticky inflation reading prior to the oil shock of the war in Iran.
03-13 23:58
Hexcel names James Coogan chief financial officer effective May 1, 2026 Hexcel appointed James Coogan as executive vice president and chief financial officer, effective May 1, 2026. Coogan will report to Tom Gentile, who is chairman, CEO and president. Coogan succeeds Mike Lenz, who has been serving
03-13 21:00
James Cropper ( ($GB:CRPR) ) just unveiled an update. James Cropper has entered...
03-10 15:28
BRIEF-Hexcel Corp - Enters Cooperation Agreement With Vision One Fund, Lp On March 3, 2026 - SEC Filing March 4 (Reuters) - Hexcel Corp HXL.N : HEXCEL CORP - ENTERS COOPERATION AGREEMENT WITH VISION ONE FUND, LP ON MARCH 3, 2026 - SEC FILING HEXCEL CORP - APPOINTS NEAL J. KEATING TO BOARD AND AUDIT
03-04 21:18
Hexcel Appoints Neal J. Keating to Board and Audit Committee Hexcel Corporation announced that Neal J. Keating has been appointed to its Board of Directors and added to the board’s Audit Committee. The appointment follows a cooperation agreement with Vision One Fund, LP and its affiliates, under whi
03-04 21:14
经济观察网 近一周,碳纤维行业动态及政策环境受到关注。2026年2月26日发布的碳纤维行业报告指出,全球碳纤维市场预计2030年突破80亿美元,中国占比超50...
03-02 04:20
经济观察网 根据赫氏(HXL.N)最新发布的财报(2025财年第四季度,报告期截至2025年12月31日)及相关公告,以下几项未来事件值得关注: 近期受关注事件...
02-20 06:40
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从39美元升至47美元;HC Wainwright & Co.:维持Agios制药"买入"评级,目标价从62美元升至65美元
02-13 15:30